Home
Concord Biotech Ltd Quarterly Result

Concord Biotech Ltd
NSE: CONCORDBIO
Net Profit - Last Quarter
Concord Biotech Ltd Quarterly Results Key Highlights
- The revenue of Concord Biotech Ltd for the Dec '24 is ₹ 260.78 crore as compare to the Sep '24 revenue of ₹ 320.21 crore.
- This represent the decline of -18.56%a1# The ebitda of Concord Biotech Ltd for the Dec '24 is ₹ 114.51 crore as compare to the Sep '24 ebitda of ₹ 143.75 crore.
- This represent the decline of -20.34%a1# The net profit of Concord Biotech Ltd for the Dec '24 is ₹ 75.92 crore as compare to the Sep '24 net profit of ₹ 95.74 crore.
- This represent the decline of -20.7%a1#.
Concord Biotech Ltd Quarterly Results Analysis
Market Price of Concord Biotech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
20 Feb 2025 | 1675.55 |
19 Feb 2025 | 1677.75 |
18 Feb 2025 | 1763.6 |
17 Feb 2025 | 1684 |
14 Feb 2025 | 1693.2 |
13 Feb 2025 | 2109.95 |
12 Feb 2025 | 2120.75 |
11 Feb 2025 | 2144.55 |
10 Feb 2025 | 2235.25 |
07 Feb 2025 | 2342.25 |
Historical Revenue of Concord Biotech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Concord Biotech Ltd
Historical EBITDA of Concord Biotech Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Concord Biotech Ltd
Historical Net Profit of Concord Biotech Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Concord Biotech Ltd
Concord Biotech Ltd News Hub
Concord Biotech consolidated net profit rises 9.36% in the June 2024 quarter
Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against
Read more
09 Aug 24
Volumes jump at Concord Biotech Ltd counter
K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Control Syst
Read more
29 Aug 24
Concord Biotech to conduct board meeting
Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2024 Pow
Read more
06 Nov 24
Concord Biotech consolidated net profit rises 18.17% in the September 2024 quarter
Net profit of Concord Biotech rose 18.17% to Rs 95.74 crore in the quarter ended September 2024 as a
Read more
11 Nov 24
Document
Concalls